Immunocore Holdings plc ADR’s recently made public that its Officer David M. Berman acquired Company’s shares for reported $5.38 million on Nov 24 ’25. In the deal valued at $39.35 per share,136,790 shares were bought.
Then, Berman David M sold 61,849 shares, generating $2,178,940 in total proceeds. Upon selling the shares at $35.23, the HEAD OF R&D now owns 0 shares.
Before that, Berman David M sold 22,532 shares. Immunocore Holdings plc ADR shares valued at $803,699 were divested by the HEAD OF R&D at a price of $35.67 per share. As a result of the transaction, Berman David M now holds 0 shares, worth roughly $0.0.
Wells Fargo initiated its Immunocore Holdings plc ADR [IMCR] rating to an Overweight in a research note published on October 31, 2025; the price target was $60. Deutsche Bank started covering the stock on May 27, 2025. It rated IMCR as “a Buy”.
Price Performance Review of IMCR
On Tuesday, Immunocore Holdings plc ADR [NASDAQ:IMCR] saw its stock jump 3.05% to $39.87. Over the last five days, the stock has gained 4.76%. Immunocore Holdings plc ADR shares have risen nearly 24.13% since the year began. Nevertheless, the stocks have risen 35.15% over the past one year. While a 52-week high of $40.17 was reached on 11/25/25, a 52-week low of $23.15 was recorded on 04/09/25.
Levels Of Support And Resistance For IMCR Stock
The 24-hour chart illustrates a support level at 39.02, which if violated will result in even more drops to 38.17. On the upside, there is a resistance level at 40.46. A further resistance level may holdings at 41.06.
How much short interest is there in Immunocore Holdings plc ADR?
A steep rise in short interest was recorded in Immunocore Holdings plc ADR stocks on 2025-11-14, growing by 0.11 million shares to a total of 8.77 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 8.66 million shares. There was a rise of 1.23%, which implies that there is a positive sentiment for the stock.
